Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/119234
Título: Phenotypic and Molecular Traits of Staphylococcus coagulans Associated with Canine Skin Infections in Portugal
Autor: Costa, Sofia Santos
Oliveira, Valéria
Serrano, Maria
Pomba, Constança
Couto, Isabel
Palavras-chave: Microbiology
Infectious Diseases
veterinary(all)
Molecular Biology
SDG 3 - Good Health and Well-being
SDG 12 - Responsible Consumption and Production
SDG 15 - Life on Land
Data: 2-Mai-2021
Resumo: Staphylococcus coagulans is among the three most frequent pathogens of canine pyoderma. Yet, studies on this species are scarce. Twenty-seven S. coagulans and one S. schleiferi, corresponding to all pyoderma-related isolations from these two species at two veterinary laboratories in Lisbon, Portugal, between 1999 and 2018 (Lab 1) or 2018 (Lab 2), were analyzed. Isolates were identified by the analysis of the nuc gene and urease production. Antibiotic susceptibility towards 27 antibiotics was evaluated by disk diffusion. Fourteen antibiotic resistance genes were screened by PCR. Isolates were typed by SmaI-PFGE. Two S. coagulans isolates (2/27, 7.4%) were methicillin-resistant (MRSC, mecA+) and four (4/27, 14.8%) displayed a multidrug-resistant (MDR) phenotype. We observed resistance to penicillin (17/27, 63.0%), fluoroquinolones (11/27, 40.7%), erythromycin and clindamycin (3/27, 11.1%), fusidic acid (3/27, 11.1%) and tetracycline (1/27, 3.7%). The blaZ and erm(B) genes were carried by 16 and 1 isolates resistant to penicillin and erythromycin/clindamycin, respectively. Only three S. coagulans carried plasmids. The single S. schleiferi isolate presented an MDR phenotype. SmaI-PFGE revealed a limited genetic diversity of S. coagulans, with a predominant lineage present from 2001 to 2018. This study describes the first MRSC causing canine infection in Portugal and reveals a high burden of antimicrobial resistance, with the emergence of MDR phenotypes within the main lineages.
Descrição: Funding Information: Funding: This work was supported by Project BIOSAFE funded by FEDER through the Programa Operacional Factores de Competitividade—COMPETE, by the Fundação para a Ciência e a Tecnologia (FCT, Portugal)—Grant LISBOA-01-0145-FEDER-030713, PTDC/CAL-EST/30713/2017 and by FCT through funds to GHTM (UID/04413/2020) and the CIISA Project (UID/CVT/00276/2020). Funding Information: This work was supported by Project BIOSAFE funded by FEDER through the Programa Operacional Factores de Competitividade?COMPETE, by the Funda??o para a Ci?ncia e a Tecnologia (FCT, Portugal)?Grant LISBOA-01-0145-FEDER-030713, PTDC/CAL-EST/30713/2017 and by FCT through funds to GHTM (UID/04413/2020) and the CIISA Project (UID/CVT/00276/2020). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Peer review: yes
URI: http://hdl.handle.net/10362/119234
DOI: https://doi.org/10.3390/antibiotics10050518
ISSN: 2079-6382
Aparece nas colecções:IHMT: MM - Artigos em revista internacional com arbitragem científica



FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.